Grade 1 Glioma clinical trials

Explore recruiting grade 1 glioma clinical trials.

Recruiting grade 1 glioma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Grade 1 Glioma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized and controlled phase II protocol in non NF1 pediatric and AYA (Adolescent and Young Adults) patients bearing a newly diagnosed low grade glioma with wild type BRAF gene comparing a daily oral MEK inhibitor (Trametinib) versus weekly vinblastine for 18 months. PLGG – MEKTRIC (Pediatric Low Grade Glioma – MEKinhibitor TRIal vs Chemotherapy)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Grade 1 Glioma trials by city

Grade 1 Glioma in Toronto Grade 1 Glioma in Vancouver Grade 1 Glioma in Montreal Grade 1 Glioma in Calgary Grade 1 Glioma in Edmonton Grade 1 Glioma in Ottawa Grade 1 Glioma in Winnipeg Grade 1 Glioma in Quebec City Grade 1 Glioma in Hamilton Grade 1 Glioma in Kitchener Grade 1 Glioma in London Grade 1 Glioma in Halifax Grade 1 Glioma in New York Grade 1 Glioma in Los Angeles Grade 1 Glioma in Chicago Grade 1 Glioma in Houston

Grade 1 Glioma clinical trials

Recruiting grade 1 glioma studies right now

Window of Opportunity Study of DSP-0390 in Gliomas

Preoperative Proton Irradiation for High-grade Brain Gliomas.

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.

Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas

Study of Letrozole in Recurrent Gliomas

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Sitagliptin in Recurrent/Progressive Grade 4 Glioma

Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells

Also recruiting in Europe

Grade 1 Glioma trials by city

Other conditions